SCHEMBL5069220

SCHEMBL5069220

C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O[Si](CC)(CC)CC)CC[C@@H]23)C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](OCCCO[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VDR P11473 12/20 0.49
▸ MAPT P10636 3/20 0.48
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ ADORA3 P0DMS8 2/20 0.48
▸ SLC6A2 P23975 2/20 0.48
▸ AGTR1 P30556 2/20 0.48
▸ NR1I2 O75469 1/20 0.48
▸ ABCB11 O95342 1/20 0.48
▸ GC P02774 1/20 0.48
▸ PGR P06401 1/20 0.48
▸ RXRA P19793 1/20 0.48
▸ CHRM3 P20309 1/20 0.48
▸ CNR1 P21554 1/20 0.48
▸ HTR2C P28335 1/20 0.48
▸ MAPK1 P28482 1/20 0.48
▸ SLC6A4 P31645 1/20 0.48
▸ ADRA1A P35348 1/20 0.48
▸ PTGS2 P35354 1/20 0.48
▸ OPRD1 P41143 1/20 0.48
▸ OPRK1 P41145 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263451 0.91 VDR (0.59) VDRMAPTSMN1; SMN2ADORA3SLC6A2
SCHEMBL24572466 0.91 VDR (0.59) VDRMAPTSMN1; SMN2ADORA3SLC6A2
SCHEMBL7271558 0.90 MAPT (0.50) VDRMAPTSMN1; SMN2ADORA3SLC6A2
SCHEMBL9201918 0.88 VDR (0.46) VDRMAPTSMN1; SMN2ADORA3SLC6A2
SCHEMBL5140676 0.86 VDR (0.45) VDRMAPTSMN1; SMN2ADORA3SLC6A2
SCHEMBL5063730 0.86 VDR (0.45) VDRMAPTSMN1; SMN2ADORA3SLC6A2
SCHEMBL5069217 0.86 VDR (0.51) VDRMAPTSMN1; SMN2ADORA3SLC6A2
SCHEMBL14489385 0.84 VDR (0.53) VDR
SCHEMBL14806585 0.82 VDR (0.54) VDRMAPTSMN1; SMN2ADORA3SLC6A2
SCHEMBL18476082 0.82 VDR (0.57) VDRMAPTSMN1; SMN2ADORA3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1061070-B1 Process for the preparation of ED-71 CHUGAI PHARMACEUTICAL CO LTD (JP) 2008-07-16 — — EP disclosed
EP-1061070-A1 24-HYDROXYVITAMIN D DERIVATIVES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2000-12-20 — — EP disclosed
Send feedback